Abstract:OBJECTIVE:To evaluate the inhibition of CD4+ CD25+ regulatory T cells (Treg) in the chronic hepatitis B patients.METHODS:Peripheral blood samples were collected from 22 patients with chronic hepatitis B (CHB) and 18 healthy blood donors to isolate the peripheral blood mononuclear cells (PBMCs). Flow cytometry was used to analyze the proportion of CD4+ CD127(lo)CD25(hi-int) Tregs in the CD4+ T cells so as to calculate the proportion of CD4+ CD25+ Tregs in the CD4+ T cells. BrdU incorporation method was used to evaluate the immune inhibition of the CD4+ CD25+ Tregs. CD4+ CD25- cells were isolated by magnetic bead sorting technique. The CD4- T cells and CD4+ CD25- T cells ere mixed and stimulated by HBVcore 18-27 peptide. The PBMCs of the CHB patients with the Treg depleted and Treg not depleted underwent detection of HBVcore18-27 specific cytotoxic T lymphocytes (CTLs). The IFN-gamma secretion of the CTLs in the PBMCs of CHB patients with Treg depleted and Treg not depleted was detected by HLA-pentamer and enzyme-linked immunospot assay (Elispot).RESULTS:The proportion of CD4+ CD127(lo)CD25(hi-int) Treg in the CD4+ T cells used to reflect the percentage of CD4+CD25+ Tregs in the CD4+ T cells of the CHB patients was 4.3% +/- 2.4%, significantly higher than that of the healthy controls (2.1% +/- 1.3%, t = 3.74, P <0.01). There was no significant difference in the inhibition of CD4+ CD25- T cells by autogenous CD4+ CD25+ T cells between the CHB patients and healthy controls. The frequency of CTLs induced by HBV core 18-27 of the CHB patients with their CD4+ CD25+ cells in circulation depleted was 0.74% +/- 0.31%, significantly higher than that of the patients whose CD4+ CD25+ cells in circulation were not depleted (0.17% +/- 0.08%, t = 4.75, P <0.01). The frequency of IFN-gamma secreting spots of HBVcore18-27-specific CD8+ T cells of the CHB patients with their CD4+ CD25+ cells depleted was (112 +/- 33), significantly higher than that of the CHB patients whose CD4+ CD25+ cells in circulation were not depleted [(23 +/- 14), t =7.828, P<0.01)].CONCLUSION:The proportion of CD4+ CD25+ Treg in CHB patients is increased compared to the healthy blood donor. The proliferative capacity of CD4+ CD25- T cells is inhibited by the presence of CD4+ CD25+ Treg dose-dependently, and the inhibition of CD4+ CD25+ Tregs in the CHB patients is similar to the inhibition of CD4+ CD25+ Tregs in healthy donors. The elimination of Treg cells followed by stimulation with HBVcore18-27 peptide significantly improves the antivirus CTL responses in CHB patients.

Effect of silencing CTLA4 with siRNA on the Th1/Th2 cytokines in peripheral blood of chronic hepatitis B patient

Inhibition of SATB1 expression in regulatory T cells contributes to hepatitis B virus-related chronic liver inflammation.

CTLA4 Silencing with Sirna Promotes Deviation of Th1/Th2 in Chronic Hepatitis B Patients.

Effect of CTLA4 on Lymphocyte Proliferative Response in Patients with Chronic Hepatitis B

Changes of the peripheral Thelper cell cytokines of patients with chronic hepatitis B during antiviral treatment

CTLA4 Expression in Peripheral Blood T Lymphocytes of Patients with Chronic Hepatitis B and Its Significance

Circulating Th2-biased T follicular helper cells impede antiviral humoral responses during chronic hepatitis B infection through upregulating CTLA4

Inhibition of CD4+ CD25+ Regulatory T Cells in Chronic Hepatitis B Patients

Effects of Regulatory T Cells on Anti-Viral Immune Responses Impaired by Chronic Hepatitis B

The research of CD4+CD25+Treg and partial cytokines from patients with chronic hepatitis B

Expression of IFN-αand IL-12 in Peripheral Blood Mononuclear Cells of Patients with Chronic Hepatitis B and Its Clinical Significance

siRNA-mediated knockdown of FoxP3 promotes the ratio of T-helper 1 (Th1) to Th2 in chronic hepatitis B patients

Expression Profiles and Function of Toll-Like Receptors 2 and 4 in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients

Circulating Cd4(+)Cd25(High) Regulatory T Cells And Expression Of Pd-1 And Btla On Cd4(+) T Cells In Patients With Chronic Hepatitis B Virus Infection

Recovery of Circulating CD56dim NK Cells and the Balance of Th17/Treg after Nucleoside Analog Therapy in Patients with Chronic Hepatitis B and Low Levels of HBsAg

Research on expression of four important molecules of CD4+CD25+ regulatory T cells In hepatitis B patients

Expressions of natural killer-associated receptors on cytotoxic T lymphocyte from peripheral blood of patients with chronic hepatitis B

The function of circulating CD4+CD25+ regulatory T cells in patients with chronic hepatitis B

Effect of Blockage of Notch1 Signaling on the Activation of T Cellular Immunity in Peripheral Blood Mononuclear Cells of Patients with Chronic Hepatitis B

Associations Between Cytotoxic T Lymphocyte-Associated Antigen-4 Polymorphisms and Serum Tumor Necrosis Factor-Α and Interferon-Γ Levels in Patients with Chronic Hepatitis B Virus Infection

[Effect of Interferon-Alpha Therapy on the Capacity of Antigen Presenting of Peripheral Blood Dendritic Cells from Patients with Chronic Hepatitis B].